NADPH oxidases 1 and 4 inhibitors (GenKyoTex)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNADPH oxidases 1 and 4 inhibitors (GenKyoTex)
Drug Alias NameNOX 1/4 inhibitors (GenKyoTex)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase 1 inhibitorsNADPH oxidase 4 inhibitors
TargetsNADPH oxidase 1NADPH oxidase 4
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalliditas Therapeutics Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalliditas Therapeutics Ab
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A